Molecular formula: | C15H21NO2 |
Average mass: | 247.338 |
Monoisotopic mass: | 247.157229 |
ChemSpider ID: | 51863 |
2 of 2 defined stereocentres
(+)-4-Propyl-9-hydroxynaphthoxazine
(+)-PHNO
(+)-trans-1a,2,3,4a,5,6-Hexahydro-9-hydroxy-4-propyl-4H-naphth-[1,2-b]-1,4-oxazine
(4aR)-trans-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol
(4aR,10bR)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol
[ACD/IUPAC Name](4aR,10bR)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol
[German]
[ACD/IUPAC Name](4aR,10bR)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphto[1,2-b][1,4]oxazin-9-ol
[French]
[ACD/IUPAC Name]2H-Naphth[1,2-b]-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, (4aR,10bR)-
[ACD/Index Name]88058-88-2
[RN]Naxagolide
[INN](2R,7R)-6-propyl-3-oxa-6-azatricyclo[8.4.0.02,7]tetradeca-1(14),10,12-trien-13-ol
(4ar,10br)-3,4,4a,5,6,10b-hexahydro-4-propyl-2H-naphth(1,2-b)-1,4-oxazin-9-ol
(4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol
(4AR,10BR)-4-PROPYL-2H,3H,4AH,5H,6H,10BH-NAPHTHO[1,2-B]MORPHOLIN-9-OL
(4AR,10BR)-4-PROPYL-2H,3H,4H,4AH,5H,6H,10BH-NAPHTHO[1,2-B]MORPHOLIN-9-OL
(4aR-trans)-3,4,4a,5,6,10b-hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol
2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, (4aR-trans)-
4-propyl-9-hydroxy-1,2,3,4a,5,6-hexahydronaphthoxazine
88058-88-2 (free base)
D(2) dopamine receptor
D(3) dopamine receptor
D(4) dopamine receptor
Dopamine receptor D4
dopazinol
DRD2_HUMAN
DRD3_HUMAN
DRD4_HUMAN
MFCD00866577
[MDL number]Naxagolida
[Spanish] [INN]naxagolida; naxagolide; naxagolidum
Naxagolide free base
Naxagolidum
[Latin] [INN]nazagolide
PHNO
Pyrido[2,3-d]pyrimidin-2(1H)-one
[ACD/IUPAC Name]Q589Y6_CANLF